Bank of America’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Bank of America’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-849	Closed	–	–	7664
2016 Q3	$0	Buy	+849	New	+$196	﹤0.01%	7587
2015 Q3	–	Sell	-1,459	Closed	-$3K	–	7635
2015 Q2	$3K	Buy	+1,459	New	+$4.5K	﹤0.01%	7007
2014 Q3	–	Sell	-14,222	Closed	-$84K	–	8340
2014 Q2	$84K	Buy	14,222 +14,122	+14,122%	+$80.1K	﹤0.01%	6279
2014 Q1	$1K	Buy	+100	New	+$902	﹤0.01%	7690

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Bank of America's TLOG Position: Q4 2016 in Review

Bank of America sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 849 shares.

Bank of America first reported a position in TLOG in Q1 2014 and held it in 4 quarters. The position peaked at $84K in Q2 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Bank of America reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Bank of America sold 849 TetraLogic Pharmaceuticals Corporation shares in Q4 2016.
Bank of America first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 4 quarters.
Bank of America's TetraLogic Pharmaceuticals Corporation position peaked at $84K in Q2 2014.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.